Inventor
SAFAR PAVEL
US14 patents
⚠️ This page may combine multiple inventors who share the name “SAFAR PAVEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AVENTIS PHARMA INC
5 patentsUS6759384B1Jul 6, 2004
Factor Xa inhibitors
AVENTIS PHARMA INC5 citations61
US6777577B2Aug 17, 2004
Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity
AVENTIS PHARMA INC1 citations60
US7393849B2Jul 1, 2008
Substituted sulfonamides and ureas useful for inhibiting kinase activity
AVENTIS PHARMA INC0 citations49
US7323457B2Jan 29, 2008
Substituted sulfonamides and ureas useful for inhibiting kinase activity
AVENTIS PHARMA INC0 citations49
US7223763B2May 29, 2007
Substituted sulfonamides and ureas useful for inhibiting kinase activity
AVENTIS PHARMA INC0 citations49
SANOFI AVENTIS DEUTSCHLAND
4 patentsUS7994168B2Aug 9, 2011
Hexahydro-pyrazino[1,2-A]pyrimidine-4,7-dione derivatives substituted with amino acids
SANOFI AVENTIS DEUTSCHLAND28 citations89
US7750005B2Jul 6, 2010
Substituted hexahydropyrazino [1,2-A] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7390814B2Jun 24, 2008
Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments
SANOFI AVENTIS DEUTSCHLAND0 citations51
US7652007B2Jan 26, 2010
Nitrogen-substituted hexahydropyrazino[1,2-A]pyrimidine-4,7-dione derivatives, processes for their preparation and their use as medicaments
SANOFI AVENTIS DEUTSCHLAND0 citations39